Enhancing Cardiopulmonary Function Through Spasticity Reduction-Effects of Botulinum Toxin A After Stroke: A...

Area of Science:

• Neurology
• Rehabilitation Medicine
• Cardiopulmonary Physiology

Background:

• Post-stroke spasticity frequently impairs mobility and functional independence.
• The impact of botulinum toxin A (BoNT-A) on cardiopulmonary exercise capacity in these patients is not well understood.

Purpose of the Study:

• To evaluate the effects of BoNT-A treatment on cardiopulmonary performance and functional outcomes in individuals with post-stroke spasticity.

Main Methods:

• A prospective before-after study involving 50 patients with post-stroke spasticity.
• Cardiopulmonary exercise testing (CPET) was conducted pre- and post-BoNT-A treatment.
• Key outcomes included peak oxygen consumption (VO2 peak), anaerobic threshold, exercise duration, maximal workload, 10 m walk test, Barthel Index, and modified Rankin Scale (mRS).

Main Results:

• Significant improvements were observed in VO2 peak, anaerobic threshold, exercise duration, and maximal workload post-treatment (p < 0.001 for all).
• Functional measures showed enhanced performance with reduced 10 m walk test times and increased Barthel Index scores (p < 0.001).
• A modest but significant reduction in disability was noted on the mRS (p = 0.003).

Conclusions:

• BoNT-A treatment demonstrated modest yet consistent improvements in cardiopulmonary exercise capacity and functional performance in post-stroke spasticity patients.
• Findings suggest potential benefits of spasticity management extending beyond localized neuromuscular effects.
• Further controlled studies are necessary to confirm these results and assess long-term clinical significance.